| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Carmine Stolfi | Q50105747 |
| P2093 | author name string | Francesco Pallone | |
| Giovanni Monteleone | |||
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Q24669747 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| NSAIDs and chemoprevention | Q28167254 | ||
| Mesalazine improves replication fidelity in cultured colorectal cells | Q28175662 | ||
| Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy | Q28176737 | ||
| COX-2 inhibition and colorectal cancer | Q28208652 | ||
| Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase | Q28280868 | ||
| Cell-cycle checkpoints and cancer | Q28293996 | ||
| 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. | Q51048836 | ||
| Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? | Q61481511 | ||
| Cancer surveillance in ulcerative colitis. Experience over 15 years | Q72556204 | ||
| Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel | Q73551359 | ||
| Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared | Q77504037 | ||
| Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis | Q79293504 | ||
| Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer | Q79378758 | ||
| Cyclin-dependent kinase pathways as targets for cancer treatment | Q28306405 | ||
| Inflammatory bowel disease | Q29616286 | ||
| Linking colorectal cancer to Wnt signaling | Q29619810 | ||
| Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies | Q33987498 | ||
| Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
| Family history as a risk factor for colorectal cancer in inflammatory bowel disease | Q34514772 | ||
| Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice | Q34530870 | ||
| Impact of EGFR expression on colorectal cancer patient prognosis and survival | Q34553435 | ||
| Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 | ||
| 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint | Q35728207 | ||
| Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study | Q36328183 | ||
| Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma | Q36403491 | ||
| Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence | Q36580628 | ||
| Colorectal cancer surveillance in inflammatory bowel disease: the search continues | Q37122138 | ||
| Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine. | Q37627928 | ||
| Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease? | Q37635008 | ||
| Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease | Q37892612 | ||
| 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. | Q39424739 | ||
| 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression. | Q39494880 | ||
| Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels | Q39981730 | ||
| Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. | Q40057258 | ||
| Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity | Q40275132 | ||
| Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells | Q40388136 | ||
| Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis | Q40721412 | ||
| Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention | Q42039909 | ||
| Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats. | Q42324127 | ||
| 5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes | Q43272637 | ||
| Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine. | Q43279593 | ||
| Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats | Q43566230 | ||
| Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells | Q44381247 | ||
| Improvement of replication fidelity by certain mesalazine derivatives. | Q44383299 | ||
| Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. | Q44755672 | ||
| The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. | Q45099623 | ||
| 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis | Q45268161 | ||
| Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas | Q46374818 | ||
| PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells | Q46547392 | ||
| 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model | Q46920668 | ||
| A positive role for the PP2A catalytic subunit in Wnt signal transduction. | Q47826110 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Wnt signaling pathway | Q155769 |
| mesalazine | Q412479 | ||
| colorectal carcinoma | Q25493920 | ||
| colorectal neoplasm | Q58833976 | ||
| cell survival | Q70690408 | ||
| P304 | page(s) | 980458 | |
| P577 | publication date | 2012-06-04 | |
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | Colorectal cancer chemoprevention by mesalazine and its derivatives | |
| P478 | volume | 2012 |
| Q28596448 | BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling |
| Q39025709 | Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. |
| Q46215033 | DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid |
| Q64272815 | Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer |
| Q92934841 | In Vitro Evaluation of the Phytopharmacological Potential of Sargassum incisifolium for the Treatment of Inflammatory Bowel Diseases |
| Q90640128 | Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer |
| Q37262181 | The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ. |
| Q26865429 | The complexities of epidemiology and prevention of gastrointestinal cancers |
| Q48182692 | The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study |
Search more.